MOAP1

MOAP1 (PNMA4) is a short-lived outer mitochondrial membrane protein that functions as a rheostat for apoptotic commitment, acting at the convergence of multiple death signals to drive BAX-dependent mitochondrial outer membrane permeabilization (PMID:17535899, PMID:16344548). Under basal conditions it is held at low abundance by constitutive ubiquitin-proteasome turnover (t½ ~25 min), and apoptotic stimuli stabilize the protein by inhibiting its polyubiquitination, allowing it to promote BAX-mediated cytochrome c release from mitochondria (PMID:17535899). Its degradation is controlled by a layered set of ubiquitin ligases: the APC/C(Cdh1) complex and the HECT ligase UBR5 (cooperating with DYRK2) target MOAP1 for destruction, while the RING ligase TRIM39 stabilizes it by antagonizing APC/C(Cdh1)-mediated ubiquitylation, and depleting the destabilizing ligases enhances BAX activation and chemosensitizes cancer cells (PMID:22529100, PMID:27721409, PMID:19100260). MOAP1 acts downstream of a RASSF1A–K-Ras axis, where activated K-Ras enhances RASSF1A binding to MOAP1 to synergistically activate BAX and induce death (PMID:16344548), and its pro-apoptotic output depends on a BH3-like (BH3L) domain (PMID:32377840). In Fas-induced hepatocyte apoptosis it operates by binding MTCH2 at the outer mitochondrial membrane to enable MTCH2-dependent recruitment of tBid to mitochondria (PMID:27320914). Beyond apoptosis, MOAP1 binds LC3 through an N-terminal LIR motif to promote phagophore closure during starvation-induced autophagy (PMID:33783314), and at the mitochondrion it interacts with MAVS to enhance RIG-I/MAVS antiviral signaling by facilitating TRIM25-mediated K63-ubiquitination of RIG-I (PMID:40929959). Structurally, MOAP1 contains a folded domain resembling the retroviral Gag capsid domain and self-assembles into RNA-containing capsid-like particles, with loss of the gene causing premature subfertility and gonadal atrophy in mice, identifying it as a domesticated Gag protein with a role in reproductive capacity (PMID:34357660, PMID:40263616).

1. 2005 High

   Established MOAP1 as the effector linking the RASSF1A–K-Ras tumor-suppressor axis to BAX activation, answering how this signaling module triggers apoptosis.

   Evidence Co-IP, shRNA knockdown, point-mutant analysis, and cell death assays in human cells

   PMID:16344548

   Open questions at the time

   • Did not define the biochemical mechanism by which MOAP1 activates BAX
   • Did not address how MOAP1 abundance is controlled
2. 2007 High

   Showed MOAP1 is a constitutively degraded, short-lived protein stabilized by apoptotic stimuli, defining abundance control as the switch governing its pro-apoptotic activity at mitochondria.

   Evidence Cycloheximide chase, ubiquitination assay, and isolated-mitochondria cytochrome c release reconstitution with in vitro-translated protein

   PMID:17535899

   Open questions at the time

   • The ubiquitin ligase responsible for basal turnover was not identified
   • The molecular interface with BAX was not resolved
3. 2008 High

   Identified TRIM39 as a stabilizing partner that extends MOAP1 half-life, providing the first positive regulator of MOAP1 abundance.

   Evidence Co-IP, ubiquitination assay, cycloheximide chase, siRNA, and isolated-mitochondria cytochrome c release assay

   PMID:19100260

   Open questions at the time

   • The destabilizing ligase that TRIM39 antagonizes was not yet known
   • Mechanism of TRIM39 inhibition of ubiquitylation undefined
4. 2012 High

   Defined APC/C(Cdh1) as the E3 ligase that degrades MOAP1 and showed TRIM39 stabilizes MOAP1 by directly inhibiting this ligase, resolving the regulatory circuit controlling MOAP1 levels.

   Evidence In vitro ubiquitylation assay, siRNA knockdown of Cdh1, and immunoprecipitation

   PMID:22529100

   Open questions at the time

   • Whether additional ligases contribute to MOAP1 turnover was not excluded
   • How apoptotic signals inhibit APC/C(Cdh1) toward MOAP1 not defined
5. 2016 High

   Genetic loss-of-function in mice established MOAP1 as physiologically required for Fas-induced hepatocyte apoptosis and revealed it acts by enabling MTCH2-mediated tBid recruitment to mitochondria.

   Evidence MOAP1-deficient mouse model, Co-IP, Fas-induced apoptosis assay, tBid mitochondrial accumulation analysis

   PMID:27320914

   Open questions at the time

   • The structural basis of the MOAP1–MTCH2 interaction was not determined
   • Whether this pathway operates outside hepatocytes was not tested
6. 2016 High

   Identified UBR5 (with DYRK2) as a second destabilizing E3 ligase for MOAP1, linking MOAP1 stabilization to chemosensitization in cisplatin-resistant cancer cells.

   Evidence Co-IP, in vitro ubiquitylation assay, siRNA knockdown, and BAX activation assay

   PMID:27721409

   Open questions at the time

   • Relative contributions of UBR5 versus APC/C(Cdh1) to MOAP1 turnover not quantified
   • DYRK2 phosphosites on MOAP1 not mapped
7. 2018 Medium

   Showed RACK1 scaffolds TRAF2 to MOAP1 to drive K63-linked ubiquitination, adding a non-degradative ubiquitin signal to MOAP1 regulation.

   Evidence Co-IP, K63-linkage-specific ubiquitination assay, and interaction mapping

   PMID:29470995

   Open questions at the time

   • The functional consequence of K63 ubiquitination on MOAP1 activity was not established
   • Single lab, no reciprocal in vivo validation
8. 2021 High

   Expanded MOAP1 function beyond apoptosis by showing it binds LC3 via an N-terminal LIR motif to drive phagophore closure in starvation-induced autophagy.

   Evidence MOAP1 knockout cells, Halo-LC3 autophagosome completion assay, proteinase K protection, Co-IP, and LIR-mutant rescue

   PMID:33783314

   Open questions at the time

   • How LC3 binding mechanically promotes membrane closure not resolved
   • Relationship between the autophagy and apoptotic functions of MOAP1 unclear
9. 2021 High

   Crystal structures revealed a Gag capsid-like fold, reclassifying MOAP1 as a domesticated retroviral Gag protein and predicting capsid self-assembly capacity.

   Evidence X-ray crystallography with structural comparison to retroviral CA domains

   PMID:34357660

   Open questions at the time

   • The structure did not address how the Gag fold relates to apoptotic or autophagy functions
   • Capsid assembly was inferred structurally, not demonstrated functionally
10. 2025 Medium

    Demonstrated that MOAP1 self-assembles into RNA-containing capsid-like particles and is required for reproductive capacity, linking its Gag ancestry to an in vivo physiological role.

    Evidence Pnma4 knockout mouse model, electron microscopy/particle analysis, and reproductive phenotype characterization

    PMID:40263616

    Open questions at the time

    • The cargo and function of the RNA-containing particles are undefined
    • Mechanistic link between capsid formation and fertility not established
    • Single lab
11. 2025 Medium

    Placed MOAP1 in innate antiviral signaling, showing it interacts with MAVS and enhances TRIM25-mediated K63-ubiquitination of RIG-I to promote interferon responses.

    Evidence Proximity-based labeling (BioID), Co-IP, Pnma4 knockout mouse with viral susceptibility, K63-ubiquitination assay at RIG-I K657

    PMID:40929959

    Open questions at the time

    • How MOAP1 facilitates the TRIM25–RIG-I reaction mechanistically is unresolved
    • Whether antiviral and apoptotic mitochondrial roles share machinery not tested
    • Single lab

• How a single Gag-derived protein integrates its distinct roles in BAX-dependent apoptosis, phagophore closure, RIG-I antiviral signaling, and capsid-mediated reproduction remains unresolved.
• No unified structural model linking the Gag capsid fold to apoptotic and autophagy activities
• Functional relationship among the multiple ubiquitin signals on MOAP1 not integrated
• Tissue-specific deployment of each function not mapped